Seq-ing answers: exploring meningioma biology utilizing bulk RNA-seq-based reference landscapes
Authors:
Open Access
- 27 August 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1631573
Abstract
Meningiomas are the most common primary brain tumors, accounting for 40% of all central nervous system neoplasms. While usually benign, these tumors can vary in aggressiveness. Traditional classification and grading systems, which primarily rely on histopathological features, are not always reliable in capturing tumor behavior and predicting patient outcomes. In contrast, modern systems—based on factors such as copy number alterations, DNA methylation, and gene expression—offer a more accurate framework for identifying distinct biological signatures and aggressive subtypes, as well as for predicting recurrence. Transcriptomic profiling using bulk whole-genome RNA sequencing (RNA-seq), which provides insights into alternative splicing, gene expression, fusion events, non-coding RNAs, and pathway activity, further enhances our understanding of meningioma tumorigenesis, enables the projection of new samples onto dimension-reduced reference landscapes, and helps accurately predict recurrence. As bulk RNA-seq becomes more accessible, it holds great potential for refining prognostic tools, informing personalized treatment approaches, and ultimately improving outcomes for meningioma patients.Keywords
This publication has 35 references indexed in Scilit:
- Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeCell Genomics, 2024
- WHO grade and pathological markers of meningiomas: Clinical and prognostic rolePathology - Research and Practice, 2023
- Meningiomas: Preoperative predictive histopathological grading based on radiomics of MRIMagnetic Resonance Imaging, 2021
- Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor GliomaCancer Cell, 2014
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutationsNature Genetics, 2013
- Anatomic location is a risk factor for atypical and malignant meningiomasCancer, 2010
- Bone Involvement Predicts Poor Outcome in Atypical MeningiomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Comparative Genomic Hybridization Analysis of Genetic Alterations Associated with Malignant Progression of MeningiomaJournal of Neuro-Oncology, 1999
- Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in Situ hybridizationCancer, 1998
- Loss of heterozygosity for chromosome 22 DNA sequences in human meningiomaCancer Genetics and Cytogenetics, 1991